[Various cellular immunity indices in patients with esophageal cancer]

It was found that 75.8% of patients with esophageal cancer respond positively to percutaneous injection of the antigen polysaccharid fraction. In patients with esophagitis the positive reaction was noted in 25% of cases. The rosette-forming capacity of lymphocytes is suppressed in 91.2% of patients with esophageal cancer. Chemoradiation treatment results in greater depression of the organism responsiveness than chemotherapy.